Delivery Order SPE2DB24D2011-SPE2DB24FBRAC

Award Date 9/3/24
Potential Completion Date 9/24/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $3,989.67 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The award is for the supply of ORGOVYX 120 MG TABLET UU 30S, a prescription medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support...
The U.S. Defense Logistics Agency (DLA) awarded a $1,329.89 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division for the supply of ORGOVYX 120 MG TABLET UU 30S pharmaceutical products. The award has an ultimate completion date of August 14, 2024. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive...
This is a delivery order award to AmerisourceBergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) for the supply of the pharmaceutical drug ORGOVYX 120 MG TABLET UU 30S. The order has a firm fixed price of $15,958.68 and a completion date of September 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025, which allows the government to efficiently procure...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,329.89 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product ORGOVYX 120 MG TABLET UU 30S. This award is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp that has a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product ORGOVYX 120 MG TABLET. The award has a ceiling value of $3,989.67 and an ultimate completion date of August 7, 2024. This delivery order is under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025. The IDC enables the DLA to efficiently procure a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, for the supply of the prescription medication ORGOVYX 120 MG TABLET UU 30S. The contract has a ceiling value of $3,989.67 and an ultimate completion date of August 20, 2024. It is a firm-fixed-price contract, which indicates the price is set and not subject to adjustment. This award is part of a larger Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.52 firm fixed-price delivery order is for the pharmaceutical product ORGOVYX 120 MG TABLET, with an ultimate completion date of April 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product ORGOVYX 120 MG TABLET UU 30S. The contract has a ceiling value of $3,989.67 and an ultimate completion date of August 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,375.85 firm fixed-price delivery order is for the medication ORGOVYX 120 MG TABLET, with a completion date of January 7, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to...
This is a $4,127.55 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ORGOVYX 120 MG TABLET to support federal government healthcare programs. It is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a...
  • SPE2DB24D2011
    Indefinite Delivery Contract
  • SPE2DB24D2011-SPE2DB24FBRAC
    Delivery Order

This is a $1,329.89 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The award is for the pharmaceutical product ORGOVYX 120 MG TABLET UU 30S, with an ultimate completion date of September 24, 2024. The order is placed under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which AmerisourceBergen holds to provide a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This contract award does not have a set-aside designation.

Generated 12/3/24, 9:54 AM